Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02400034 · ClinicalTrials.gov registry record · NA

Comparing Voiding Trials After Midurethral Sling for Stress Incontinence

A NA study, sponsored by Northwell Health.

Completed
Registry status
NA
Development phase
112
Enrollment target

NCT02400034: Completed NA study, sponsored by Northwell Health.

NCT02400034 is a NA study that has completed, run by Northwell Health. The registered enrollment target is 112 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02400034, a NA study, has completed, sponsored by Northwell Health.

COMPLETED
Registry status
NA
Development phase
112 participants
Enrollment target

Study Summary

Urinary incontinence is a prevalent health and quality of life concern affecting almost half of women over the age of 20. Urinary retention (abnormal holding of urine) is a concern of many surgeons who perform midurethral sling surgery. All patients after outpatient midurethral sling or vaginal prolpase surgery must complete a voiding trial if they are to be discharged without a catheter. The purpose of this study is to compare two different types of postoperative voiding trials to determine which leads to less post-operative issues, such as urinary retention requiring catheterization. You are being asked to participate because you are having midurethral sling surgery, either with or without vaginal prolapse repair.

Primary Outcome

Any additional visit outside the patient's scheduled postoperative visits to the emergency room, urgent care facility or doctor's office will be recorded for up to 6 six weeks postoperatively

Interventions

  • OTHER Voiding trial

Trial Details

FieldValue
Enrollment Target 112 participants
Start Date 2015-03
Est. Completion 2016-06
Phase NA
Northwell Health

370 total trials

What the finished NCT02400034 record still lists

NCT02400034 is an interventional study that assigns participants to a tested intervention. The registered 112 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 1 intervention - of which Voiding trial is the first listed.

NCT02400034 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02400034 about?

NCT02400034 is a clinical study titled "Comparing Voiding Trials After Midurethral Sling for Stress Incontinence". Urinary incontinence is a prevalent health and quality of life concern affecting almost half of women over the age of 20. Urinary retention (abnormal holding of urine) is a concern of many surgeons who perform midurethral sling surgery. All patients after outpatient midurethral sling or vaginal prol...

What is the current status of trial NCT02400034?

This trial is currently completed. It is a NA study. The enrollment target is 112 participants. The study started on 2015-03. Estimated completion is 2016-06.

What interventions are being tested in trial NCT02400034?

The interventions under investigation include: Voiding trial (OTHER).

Who is sponsoring clinical trial NCT02400034?

This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02400034's enrollment target sits among peer trials

112 813th of 2000 higher than 1,185 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04511013 · 112 participants · Phase 2

    A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

  • NCT04551560 · 112 participants · NA

    Stress and Congestive Heart Failure

  • NCT04872166 · 112 participants · Phase 1

    A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer

  • NCT05024773 · 112 participants · Phase 3

    Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02400034, the US trial registry maintained by the National Library of Medicine. NCT02400034 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.